Shrydus Industries Ltd

Shrydus Industries Ltd

BBSE:SHRYDUS
3.22
INR
-0.03
(-0.92%)
-0.96EPS
138.78MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.02
0.01
0.43
0.26
0.23
- -
5.09
2.43
8.82
9.1
6.99
12.43
0.06
0.34
Basic EPS, GAAP
-0.14
0.1
-0.16
-0.1
-0.01
-2.33
-0.05
-0.26
0.04
0.29
0.39
2.58
-0.02
-0.96
Free Cash Flow per Basic Share
-0.12
-3.42
0.24
0.07
0.04
- -
0.12
-0.3
-1.48
-0.15
-9.94
-7.96
0.03
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
3.47
3.57
3.41
3.31
3.3
0.96
0.92
0.65
0.7
1.76
4.41
15.8
15.78
- -
Tangible Book Value per Share
3.47
3.57
3.41
3.31
3.3
0.96
0.92
0.65
0.7
1.76
4.41
15.8
15.78
- -
Basic Weighted Avg Shares
10
10
10
10
10
10
10
10
10
10
14
32
32
30
Sales/Revenue/Turnover
- -
- -
4
3
2
- -
52
25
90
93
95
398
2
10
Operating Margin (%)
-869.82
-9,818.01
-34.32
-40.71
7.12
-51,460.08
-0.91
-10.84
0.61
2.87
5.55
20.79
-32.05
-287.14
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
1
-2
-1
- -
-24
- -
-3
- -
3
5
83
-1
-29
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
18.52
- -
- -
0.04
- -
- -
Profit Margin (%)
-830.36
785.09
-37.27
-39.95
-4.3
-50,083.34
-0.88
-10.85
0.49
3.22
5.55
20.76
-26
-285.92
Working Capital
- -
32
30
22
22
2
4
4
19
32
40
194
184
- -
LT Debt
3
- -
4
- -
1
- -
- -
2
17
19
109
- -
- -
- -
Total Equity
35
36
35
34
34
10
9
7
7
19
60
506
505
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
2.64
- -
5.08
24.51
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
2.63
- -
5.08
24.5
- -
- -
Return on Common Equity (%)
-4.09
2.97
-4.59
-3.11
-0.29
-109.54
-4.79
-33.57
6.38
22.82
13.32
29.23
-0.1
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
31
32
32
Market Capitalization
137
85
139

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
185
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
116
- -
Inventories
- -
38
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
102.73%
226.97%
-0.1%
Free Cash Flow
- -
1,803.47%
-100.43%
Net Income, GAAP
2,611.43%
382.77%
-100.63%
Sales/Revenue/Turnover
10,950.52%
97.85%
-99.5%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
10
35
353
- -
398
2026
- -
- -
2
- -
2
2027
8
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.04
0.85
2.33
-0.86
2.58
2026
-0.02
-0.01
0.02
-0.01
-0.02
2027
-0.9
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Premal Shailesh Parekh
Full Time Employees
4
Sector
Finance
Industry
Investment banks/Brokers
Address
107, Sagar Avenue Kolkata India 400058
IPO Date
Jan 4, 1995
Business
Shrydus Industries Ltd engages in trading agricultural commodities, manufacturing pharmaceutical formulations including tablets and capsules, real estate development, and retail mobilization services in India. The company, formerly known as VCK Capital Market Services Ltd, changed its name in May 2023 and operates from its headquarters in Kolkata, West Bengal, with additional locations in Mumbai and Siliguri; founded in 1983, it maintains a small workforce of approximately 18 employees and trades on the BSE under the ticker SHRYDUS.BO. Core products and services encompass trading in various agricultural commodities such as grains and produce; production of pharmaceuticals through an export-oriented facility capable of 20 million tablets and 4 million capsules daily across over 400 registered products; real estate property development; and financial services including investment banking, project appraisals, resource raising, and structural planning for clients. In recent developments, Shrydus Industries launched a rights issue in August 2024 raising approximately Rs 36 crore to fund the acquisition of Astra Lifecare (India) Private Ltd's 100% export-oriented pharmaceutical plant in Gujarat, repayment of related-party loans, working capital needs, and general corporate purposes. The company continues to diversify from its historical commodities trading and financial services roots into pharmaceuticals and green energy sectors, leveraging strategic client relationships and expansion in export markets across Southeast Asia, Latin America, and Central America. Operations remain focused on the Indian market with international distribution networks for pharmaceutical exports.